Results 291 to 300 of about 6,027,899 (340)

An insight into the pharmaceutical sector in Yemen during conflict: challenges and recommendations

Medicine, Conflict and Survival, 2020
In our world today, we need to understand, measure, and respond to inequality. The conflict and siege in Yemen have caused serious repercussions and consequences for the pharmaceutical sector and health of the people.
Mohammed Alshakka, M. I. Mohamed Ibrahim, A. Bahattab, Wafa F. S. Badulla, P. Shankar   +4 more
semanticscholar   +1 more source

Pharmaceutical sector: Delicate transition

Nature, 2012
With lay-offs rife in the drug industry, life scientists and chemists are seeking fresh career paths.
openaire   +2 more sources

Scope economies in the pharmaceutical sector

Rivista Internazionale di Scienze Economiche e Commerciali, 2006
The paper’s objectives are twofold: to propose an experimental simulation to measure scope economies between pairs of submarkets and to point out the role of submarkets in explaining the concentration level in the pharmaceutical market. We simulate scope economies consistent with the diversification choices of large international companies in the years
openaire   +2 more sources

Blockchain in Pharmaceutical Sector

2020
The pharmaceutical research and development is a composite process that grabs lots of years in drug discovery, drug development and regulatory approval in the supply chain in the pharmaceutical sector. But due to the drugs counterfeiting, such as hidden, uncontrolled and outdated information of drug regulatory authority and manufacturers over drugs ...
Meet Kumari, Meenu Gupta, Chetanya Ved
openaire   +1 more source

Monopoly in the pharmaceutical sector

Pharmaceuticals Policy and Law, 2010
Almost every EU country has a form of regulation for the pharmaceutical sector, the level of which varies by country, motivated by the unique nature of medicine as a consumers good, different from any other good. In the majority of EU countries this circumstance allows the monopoly of the profession to extend to the dispensing of all medicine subject ...
openaire   +1 more source

The pharmaceuticals sector in Vietnam

2016
The fundamental goal of competition law is to support productivity and innovativeness; in fact, the short-term effect of enforcement actions is often a reduction in product prices. This book reports the findings of consumer market studies into a range of goods and services in developing countries in Africa, Asia and Latin America.
Que Anh Pham, Tran Phuong Lan
openaire   +1 more source

Innovation, competition, and the pharmaceutical sector: theory and practice

Journal of European Competition Law & Practice
With high-technology markets coming increasingly under scrutiny from a competition law perspective, scholars and institutions have increasingly highlighted the relevance of innovation-related considerations in competition law analyses.Fortunately, there is a rich theoretical debate on the innovation-competition relationship, in particular by Smith ...
Jacquelyn Veraldi, Alicja Sołtykowska
openaire   +1 more source

Different Facets of Competition in the Pharmaceutical Sector: Preliminary Findings of the European Commission’s Sector Inquiry into Pharmaceuticals

Archivum Immunologiae et Therapiae Experimentalis, 2010
The pharmaceutical sector is a part of today's economy in which the relationship between patents and competition has been receiving increasing attention. The European Commission's inquiry into this sector adds to the ongoing debate. Its Preliminary Report, published in November 2008, explains and quantifies a number of practices adopted by individual ...
openaire   +2 more sources

The Irish pharmaceutical sector

Foreign multinational enterprises (MNEs) have played an important role in the development of the Irish economy in recent decades. Since the economic recovery began in 2014 after the financial crash, approximately half of the growth in the economy has come from the expansion in output of these MNEs (FitzGerald, 2023).
openaire   +3 more sources

Public subsidies for R&D and public sector pharmaceutical innovation

Applied Economics, 2021
Dimitrios Kourouklis
exaly